These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3952805)

  • 21. Critical ketoconazole dosage range for ciclosporin clearance inhibition in the dog.
    Myre SA; Schoeder TJ; Grund VR; Wandstrat TL; Nicely PG; Pesce AJ; First MR
    Pharmacology; 1991; 43(5):233-41. PubMed ID: 1784623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
    Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR
    Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic monitoring of cyclosporine: impact of a change in standards on 125I-monoclonal RIA performance in comparison with liquid chromatography.
    Keown PA; Glenn J; Denegri J; Maciejewska U; Seccombe D; Stawecki M; Freeman D; Stiller C; Shackleton C; Cameron E
    Clin Chem; 1990 May; 36(5):804-7. PubMed ID: 2337993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclosporin A pharmacokinetics and efficacy in the treatment of atopic dermatitis in dogs.
    Steffan J; Strehlau G; Maurer M; Rohlfs A
    J Vet Pharmacol Ther; 2004 Aug; 27(4):231-8. PubMed ID: 15305852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The TDx assay for cyclosporine and its metabolites in blood samples compared with HPLC and RIA methods.
    Zucchelli GC; Pilo A; Clerico A; Masini S; Zoppi F; Bovati ML; Spaggiari P; Bertelli A
    Drugs Exp Clin Res; 1989; 15(4):185-8. PubMed ID: 2673715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of cyclosporin A in the serum of kidney transplant patients by rapid-flow fractionation and normal-phase high-performance liquid chromatography.
    Oka K; Hosoda K; Hirano T; Sakurai E; Kozaki M
    J Chromatogr; 1989 May; 490(1):145-54. PubMed ID: 2668308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The kinetics of cyclosporine and its metabolites in bone marrow transplant patients.
    Schwinghammer TL; Przepiorka D; Venkataramanan R; Wang CP; Burckart GJ; Rosenfeld CS; Shadduck RK
    Br J Clin Pharmacol; 1991 Sep; 32(3):323-8. PubMed ID: 1777368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclosporin A: correlation between HPLC and RIA serum levels.
    Abisch E; Beveridge T; Gratwohl A; Niederberger W; Nussbaumer K; Schaub P; Speck B; Trapp M
    Pharm Weekbl Sci; 1982 Jun; 4(3):84-6. PubMed ID: 7110912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The interaction of the diltiazem with oral and intravenous cyclosporine in rats.
    Kalkan S; Gumustekin M; Aygoren O; Tuncok Y; Gelal A; Guven H
    Eur J Drug Metab Pharmacokinet; 2004; 29(2):119-23. PubMed ID: 15230340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of the clinical utility of the radioimmunoassay, high-performance liquid chromatography, and TDx cyclosporine assays in outpatient renal transplant recipients.
    Schroeder TJ; Brunson ME; Pesce AJ; Hindenlang LL; Mauser PA; Ruckrigl DI; Weibel ML; Wadih G; First MR
    Transplantation; 1989 Feb; 47(2):262-6. PubMed ID: 2645710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Measuring cyclosporin in immunosuppressive treatment following liver and heart transplantation].
    Hamilton G; Roth E; Mühlbacher F; Funovics J; Piza F; Schindler J; Woloszcuk W; Havel M; Laczkovics A
    Wien Klin Wochenschr; 1986 Dec; 98(24):820-4. PubMed ID: 3548080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclosporine metabolite cross-reactivity in different cyclosporine assays.
    Murthy JN; Yatscoff RW; Soldin SJ
    Clin Biochem; 1998 Apr; 31(3):159-63. PubMed ID: 9629489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclosporine pharmacokinetics in liver transplant recipients: evaluation of results using both polyclonal radioimmunoassay and liquid chromatographic analysis.
    Tredger JM; Grevel J; Naoumov N; Steward CM; Niven AA; Whiting B; Williams R
    Eur J Clin Pharmacol; 1991; 40(5):513-9. PubMed ID: 1884727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclosporine kinetics in healthy volunteers.
    Ptachcinski RJ; Venkataramanan R; Burckart GJ; Gray JA; Van Thiel DH; Sanghvi A; Rosenthal JT
    J Clin Pharmacol; 1987 Mar; 27(3):243-8. PubMed ID: 3680581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioavailability assessment of cyclosporine in the rat. Influence of route of administration.
    Luke DR; Brunner LJ; Vadiei K
    Drug Metab Dispos; 1990; 18(2):158-62. PubMed ID: 1971566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunosuppressive metabolites of cyclosporine in the blood of renal allograft recipients.
    Rosano TG; Freed BM; Cerilli J; Lempert N
    Transplantation; 1986 Sep; 42(3):262-7. PubMed ID: 2944258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The preparation and evaluation of a tablet dosage form of cyclosporine in dogs.
    Abdallah HY; Mayersohn M
    Pharm Res; 1991 Apr; 8(4):518-22. PubMed ID: 1871050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic profiles of cyclosporine in rats. Influence of route of administration and dosage.
    Wassef R; Cohen Z; Langer B
    Transplantation; 1985 Nov; 40(5):489-93. PubMed ID: 3877356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of liver dysfunction on cyclosporine pharmacokinetics--a comparison between 70 per cent hepatectomy and complete bile duct ligation in dogs.
    Takaya S; Iwatsuki S; Noguchi T; Koie H; Zaghloul I; Venkataramanan R; Starzl TE
    Jpn J Surg; 1989 Jan; 19(1):49-56. PubMed ID: 2733278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.